SCHEMBL30734191

SCHEMBL30734191

Nc1cc(-c2ccc3ncnc(N4CCCN(Cc5ccc(F)cc5)CC4)c3c2)ccn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.55
BACE1 P56817 4/20 0.55
AURKA O14965 1/20 0.55
HTT P42858 3/20 0.49
RPS6KB1 P23443 2/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
LMNA P02545 2/20 0.44
MAP4K4 O95819 1/20 0.44
ATM Q13315 1/20 0.43
ALDH1A1 P00352 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
CLK4 Q9HAZ1 2/20 0.42
USP2 O75604 1/20 0.42
HIF1A Q16665 1/20 0.42
KDM4E B2RXH2 1/20 0.42
OPRM1 P35372 1/20 0.41
OPRK1 P41145 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30734134 0.96 ACHE (0.58) ACHEBACE1AURKAHTTRPS6KB1
SCHEMBL30734233 0.83 ACHE (0.55) ACHEBACE1HTTMEN1KMT2A
SCHEMBL30734139 0.83 ACHE (0.56) ACHEBACE1AURKAHTTRPS6KB1
SCHEMBL30734208 0.81 HTT (0.61) ACHEBACE1AURKAHTTRPS6KB1
SCHEMBL30734212 0.79 HTT (0.49) HTTMEN1KMT2ALMNAMAP4K4
SCHEMBL30734186 0.78 ACHE (0.60) ACHEBACE1AURKAHTTRPS6KB1
SCHEMBL30734148 0.77 HTT (0.67) ACHEBACE1AURKAHTTRPS6KB1
SCHEMBL31745382 0.77 ACHE (0.53) ACHEBACE1MEN1KMT2ALMNA
SCHEMBL31745229 0.76 CYP1A2 (0.52) HTTMEN1KMT2ALMNAALDH1A1
SCHEMBL30734169 0.76 CYP3A4 (0.54) MEN1KMT2ALMNAALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382301-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF UNIV ARIZONA (US) 2025-12-18 US disclosed
EP-4543888-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF Arizona Board of Regents on behalf of The University of Arizona (US) 2025-04-30 EP disclosed
WO-2023250083-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2023-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382301-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF CLK2, CLK3, CLK1 ACHE 3704/4885BACE1 1412/4885AURKA 397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.